Goldman Sachs’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-494,248
| Closed | -$47.9M | – | 4433 |
|
|
2019
Q3 | $47.9M | Sell |
494,248
-61,546
| -11% | -$5.97M | 0.01% | 1006 |
|
|
2019
Q2 | $56.9M | Sell |
555,794
-580,300
| -51% | -$59.4M | 0.02% | 954 |
|
|
2019
Q1 | $129M | Buy |
1,136,094
+303,081
| +36% | +$34.5M | 0.04% | 492 |
|
|
2018
Q4 | $32.6M | Buy |
833,013
+386,635
| +87% | +$15.1M | 0.01% | 1227 |
|
|
2018
Q3 | $24.4M | Buy |
446,378
+150,068
| +51% | +$8.19M | 0.01% | 1535 |
|
|
2018
Q2 | $24.5M | Buy |
296,310
+171,777
| +138% | +$14.2M | 0.01% | 1503 |
|
|
2018
Q1 | $8.29M | Sell |
124,533
-230,839
| -65% | -$15.4M | ﹤0.01% | 2038 |
|
|
2017
Q4 | $18.3M | Sell |
355,372
-218,826
| -38% | -$11.3M | ﹤0.01% | 1597 |
|
|
2017
Q3 | $51.2M | Sell |
574,198
-46,439
| -7% | -$4.14M | 0.01% | 1056 |
|
|
2017
Q2 | $37.1M | Buy |
620,637
+70,576
| +13% | +$4.22M | 0.01% | 1198 |
|
|
2017
Q1 | $29.3M | Buy |
550,061
+51,954
| +10% | +$2.77M | 0.01% | 1318 |
|
|
2016
Q4 | $24.9M | Buy |
498,107
+19,160
| +4% | +$956K | 0.01% | 1382 |
|
|
2016
Q3 | $28.8M | Buy |
478,947
+140,495
| +42% | +$8.44M | 0.01% | 1289 |
|
|
2016
Q2 | $17.3M | Buy |
338,452
+281,187
| +491% | +$14.4M | 0.01% | 1459 |
|
|
2016
Q1 | $1.69M | Buy |
57,265
+52,510
| +1,104% | +$1.55M | ﹤0.01% | 2614 |
|
|
2015
Q4 | $215K | Buy |
4,755
+3,389
| +248% | +$153K | ﹤0.01% | 3693 |
|
|
2015
Q3 | $57K | Sell |
1,366
-9,132
| -87% | -$381K | ﹤0.01% | 4318 |
|
|
2015
Q2 | $633K | Sell |
10,498
-1,098
| -9% | -$66.2K | ﹤0.01% | 3182 |
|
|
2015
Q1 | $899K | Buy |
+11,596
| New | +$899K | ﹤0.01% | 2980 |
|